Dr. Josep Gámez, head of the Peripheral Nervous System group of the Vall d’Hebron Research Institute (VHIR) and coordinator of the CSUR Rare Neuromuscular Diseases, the CSUR of Ataxias and Hered...
Researchers at IBEC have identified a potential way to slow down the neurodegenerative progression of Parkinson’s disease. They focused their work on the cellular prion protein (PrPc), a specialized...
The work, coordinated by the Ikerbasque researcher Aitor Hierro, has been published in Cell, the journal with the highest impact factor in the field of biomedicine and molecular biology. The research ...
Study shows mGluR4 positive allosteric modulator is safe and well tolerated at doses well above those that produce robust effects in Parkinson’s disease animal models
Researchers from Hospital Clínic and IDIBAPS have shown for the first time that it is possible to diagnose Parkinson’s disease (PD) in people with sleep disorders through a biopsy. This test is per...